NEW YORK (GenomeWeb News) – BioNanomatrix will use two new grants totaling $833,000 from the National Human Genome Research Institute to continue developing and evaluating its genomic nanoscale imaging and analysis platform, the company said today.

The Philadelphia-based firm said it will use the Small Business Innovation Research grant funding to prepare for planned commercial launch of the NanoAnalyzer system, which is scheduled for the second quarter of 2010.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.